Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fibrin sealant - Grifols

Next Previous
Drug Profile

Fibrin sealant - Grifols

Alternative Names: FS Grifols; Human fibrinogen/human thrombin - Grifols; VeraSeal; VISTASEALTM

Latest Information Update: 01 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Grifols
  • Class Acute-phase proteins; Adhesives; Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Serine endopeptidases
  • Mechanism of Action Fibrinogen replacements; Thrombin replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Surgical blood loss

Most Recent Events

  • 29 Oct 2024 Registered for Surgical blood loss (In children, In adolescents, In infants) in USA (Topical)
  • 20 May 2022 Grifols Therapeutics completes a phase III trial in Surgical blood loss (Adjunctive treatment, In adolescents, In infants, In children) in USA, Bulgaria, France, Hungary, Romania, Serbia, and United Kingdom (Topical) (NCT03461406)
  • 03 Mar 2021 Fibrin sealant is still in phase III trial for Surgical blood loss (In adolescents, In children, In infants) in USA, Bulgaria, Hungary, France, Romania, Serbia and United Kingdom (Topical) (NCT03461406)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top